Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Kirkeby, Agnete  [Clear All Filters]
2014
Grealish S, Diguet E, Kirkeby A, Mattsson B, Heuer A, Bramoulle Y, Van Camp N, Perrier AL, Hantraye P, Björklund A, et al. Human ESC-Derived Dopamine Neurons Show Similar Preclinical Efficacy and Potency to Fetal Neurons when Grafted in a Rat Model of Parkinson's Disease. Cell Stem Cell. 2014;15(5):653-665.
2016
Heuer A, Jönsson ME, Pfisterer U, Kirkeby A, Parmar M. hESC-derived neural progenitors prevent xenograft rejection through neonatal desensitisation. Exp Neurol. 2016.
2018
Cardoso T, Adler A, Mattsson B, Hoban DB, Nolbrant S, Wahlestedt JNelander, Kirkeby A, Grealish S, Björklund A, Parmar M. Target-specific forebrain projections and appropriate synaptic inputs of hESC-derived dopamine neurons grafted to the midbrain of parkinsonian rats. J Comp Neurol. 2018.
2020
Korshunova I, Rhein S, García-González D, Stölting I, Pfisterer U, Barta A, Dmytriyeva O, Kirkeby A, Schwaninger M, Khodosevich K. Genetic modification increases the survival and the neuroregenerative properties of transplanted neural stem cells. JCI Insight. 2020.
2022
Dubonyte U, Asenjo-Martinez A, Werge T, Lage K, Kirkeby A. Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells. Acta Neuropathol Commun. 2022;10(1):183.
2023
Rifes P, Isaksson M, Rusimbi C, Santonja ARamón, Nelander J, Laurell T, Kirkeby A. Identifying secreted biomarkers of dopaminergic ventral midbrain progenitor cells. Stem Cell Res Ther. 2023;14(1):354.
Häfner SJ, Jansson MD, Altinel K, Andersen KL, Abay-Nørgaard Z, Ménard P, Fontenas M, Sørensen DM, Gay DM, Arendrup FS, et al. Ribosomal RNA 2'-O-methylation dynamics impact cell fate decisions. Dev Cell. 2023.
Garza R, Sharma Y, Atacho DAM, Thiruvalluvan A, Hamdeh SAbu, Jönsson ME, Horvath V, Adami A, Ingelsson M, Jern P, et al. Single-cell transcriptomics of human traumatic brain injury reveals activation of endogenous retroviruses in oligodendroglia. Cell Rep. 2023:113395.
2024
Christiansen JRågård, Kirkeby A. Clinical translation of pluripotent stem cell-based therapies: successes and challenges. Development. 2024;151(7).
Novoa JJ, Westra IM, Steeneveld E, Neves NFonseca, Arendzen CH, Rajaei B, Grundeken E, Yildiz M, van der Valk W, Salvador A, et al. Good Manufacturing Practice-compliant human induced pluripotent stem cells: from bench to putative clinical products. Cytotherapy. 2024.